25-Feb-2026 3:05 PM CST - Business Wire Schrdinger Reports Fourth Quarter and Full-Year 2025 Financial Results Schrdinger, Inc. (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2025, and provided its 2026 outlook and 2028 financial objectives. "Schrdingers performance in 2025, marked by 23% total revenue growth and 11% software revenue growth, is a testament to the resilience of our business and the unique value we provide," said Ramy Farid, Ph.D., chief executive officer of Schrdinger. While the drug discovery AI la
24-Feb-2026 7:30 AM CST - Business Wire Schrdinger to Participate in Upcoming Investor Conferences Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 46th Annual Health Care Conference: Fireside chat on Tuesday, March 3, 2026 at 9:50 a.m. E.T. Leerink Global Healthcare Conference 2026: Fireside chat on Tuesday, March 10, 2026 at 1:40 p.m. E.T. KBCM Healthcare Forum: Fireside chat on Tuesday, March 17, 2026 at 9:00 a.m. E.T. The live discussions can be accessed in the Investors section
11-Feb-2026 7:30 AM CST - Business Wire Schrdinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 Schrdinger, Inc. (Nasdaq: SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its comput
6-Nov-2025 7:30 AM CST - Business Wire Schrdinger to Present at Jefferies London Healthcare Conference Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00 p.m. GMT (11:00 a.m. ET). The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with i
5-Nov-2025 3:05 PM CST - Business Wire Schrdinger Reports Third Quarter 2025 Financial Results Schrdinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended September 30, 2025. "Schrdinger delivered a solid third quarter with software revenue growth of 28%, reflecting the industrys increasing demand for our leading computational platform, said Ramy Farid, Ph.D., chief executive officer of Schrdinger. While we are encouraged by the continued high level of customer engagement as the macroeconomic pressures that have affected the in
22-Oct-2025 7:30 AM CST - Business Wire Schrdinger to Announce Third Quarter 2025 Financial Results on November 5 Schrdinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its computational platform, whic
27-Aug-2025 7:30 AM CST - Business Wire Schrdinger to Present at Morgan Stanley Global Healthcare Conference Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The live presentation will take place on Monday, September 8, 2025 at 11:30 a.m. E.T. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery wi
25-Jul-2025 7:30 AM CST - Business Wire Schrdinger to Announce Second Quarter 2025 Financial Results on August 6 Schrdinger (Nasdaq: SDGR) will report its second quarter 2025 financial results on Wednesday, August 6, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its computational platform, which
22-May-2025 7:30 AM CST - Business Wire Schrdinger to Present at Jefferies Global Healthcare Conference Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its computational
25-Feb-2026 3:05 PM CST - Business Wire Schrdinger Reports Fourth Quarter and Full-Year 2025 Financial Results Schrdinger, Inc. (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2025, and provided its 2026 outlook and 2028 financial objectives. "Schrdingers performance in 2025, marked by 23% total revenue growth and 11% software revenue growth, is a testament to the resilience of our business and the unique value we provide," said Ramy Farid, Ph.D., chief executive officer of Schrdinger. While the drug discovery AI la
24-Feb-2026 7:30 AM CST - Business Wire Schrdinger to Participate in Upcoming Investor Conferences Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 46th Annual Health Care Conference: Fireside chat on Tuesday, March 3, 2026 at 9:50 a.m. E.T. Leerink Global Healthcare Conference 2026: Fireside chat on Tuesday, March 10, 2026 at 1:40 p.m. E.T. KBCM Healthcare Forum: Fireside chat on Tuesday, March 17, 2026 at 9:00 a.m. E.T. The live discussions can be accessed in the Investors section
11-Feb-2026 7:30 AM CST - Business Wire Schrdinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 Schrdinger, Inc. (Nasdaq: SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its comput
6-Nov-2025 7:30 AM CST - Business Wire Schrdinger to Present at Jefferies London Healthcare Conference Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00 p.m. GMT (11:00 a.m. ET). The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with i
5-Nov-2025 3:05 PM CST - Business Wire Schrdinger Reports Third Quarter 2025 Financial Results Schrdinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended September 30, 2025. "Schrdinger delivered a solid third quarter with software revenue growth of 28%, reflecting the industrys increasing demand for our leading computational platform, said Ramy Farid, Ph.D., chief executive officer of Schrdinger. While we are encouraged by the continued high level of customer engagement as the macroeconomic pressures that have affected the in
22-Oct-2025 7:30 AM CST - Business Wire Schrdinger to Announce Third Quarter 2025 Financial Results on November 5 Schrdinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its computational platform, whic
27-Aug-2025 7:30 AM CST - Business Wire Schrdinger to Present at Morgan Stanley Global Healthcare Conference Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The live presentation will take place on Monday, September 8, 2025 at 11:30 a.m. E.T. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery wi
25-Jul-2025 7:30 AM CST - Business Wire Schrdinger to Announce Second Quarter 2025 Financial Results on August 6 Schrdinger (Nasdaq: SDGR) will report its second quarter 2025 financial results on Wednesday, August 6, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its computational platform, which
22-May-2025 7:30 AM CST - Business Wire Schrdinger to Present at Jefferies Global Healthcare Conference Schrdinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T. The live webcast can be accessed in the Investors section of Schrdingers website and will be archived for approximately 90 days following the event. About Schrdinger Schrdinger is transforming molecular discovery with its computational
